Literature DB >> 1298988

Pulmonary thromboembolism in thalassemic patients.

D Sonakul1, S Fucharoen.   

Abstract

Chronic pulmonary thromboembolism plays an important role in cardiac failure which is a major cause of death in thalassemic patients over 20 years of age. This report is a study of autopsy lung tissue from 58 patients with beta-thalassemia/hemoglobin E disease (beta-thal/HbE), including whole lungs from five, 13 patients with hemoglobin H disease (HbH), and eight patients with beta-thalassemia major (beta-thal) including whole lung from one. Pulmonary thromboembolic lesions were found in 24 of 58 (41%) patients with beta-thal/HbE, of which 21 of 39 (54%) were splenectomized patients and 3 of 19 (16%) were nonsplenectomized patients, with the incidence increasing with age. Lung maps showed the greatest number of lesions in the lingula, right middle lobe, and anterior segments of both upper lobes. Pulmonary thromboembolic lesions were also found in one of 13 HbH patients and one of 8 beta-thal patients, both splenectomized. Eight of the 27 patients with these lesions had right ventricular and 14 biventricular hypertrophy, reflecting the deleterious effect of such lesions. Possible causative factors are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1298988

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  14 in total

1.  Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.

Authors:  A Phrommintikul; A Sukonthasarn; R Kanjanavanit; W Nawarawong
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 2.  Pulmonary thromboembolism in children.

Authors:  Paul S Babyn; Harpal K Gahunia; Patricia Massicotte
Journal:  Pediatr Radiol       Date:  2005-01-06

Review 3.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

Review 4.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

5.  Pulmonary hypertension in patients with hematological disorders following splenectomy.

Authors:  V Meera; Farah Jijina; Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2010-08-04       Impact factor: 0.900

6.  Pulmonary hypertension in patients with hematological disorders following splenectomy.

Authors:  Kanjaksha Ghosh; V Meera; Farah Jijina
Journal:  Indian J Hematol Blood Transfus       Date:  2009-07-05       Impact factor: 0.900

7.  Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.

Authors:  Vichai Atichartakarn; Khanchit Likittanasombat; Suporn Chuncharunee; Pakorn Chandanamattha; Surapon Worapongpaiboon; Pantep Angchaisuksiri; Katcharin Aryurachai
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

8.  Vascular endothelial growth factor in children with thalassemia major.

Authors:  Sameh S Fahmey; Hassan F Naguib; Sanna S Abdelshafy; Rasha E Alashry
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-05       Impact factor: 2.576

9.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

Review 10.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.